ENTITY
Biocon Ltd

Biocon Ltd (BIOS IN)

150
Analysis
Health CareIndia
Biocon Ltd., is an integrated biotechnology enterprise with a presence in biopharmaceuticals, enzymes, custom research and clinical research. The Company's pharmaceutical products include statins, immunosuppressants and anti-diabetic drugs. Biocon also manufactures specialty enzymes and new enzyme applications besides providing clinical and custom research services.
more
06 Jul 2025 08:30

APAC Healthcare Weekly (July 6)- Shionogi, Simcere, Wuxi XDC, Sino Bio, Apollo Hosp, Torrent Pharma

Simcere, CSPC, and Sino Bio got approvals for their new drugs in China. Apollo Hospital announced a demerger. Torrent is acquiring controlling...

Logo
676 Views
Share
29 Jun 2025 08:30

APAC Healthcare Weekly (June 29)- RemeGen, Innovent, Daiichi, SanBio, Otsuka, Chugai, Glenmark

Last week couple of Chinese companies signed outlicensing deals with international players. Innovent got weight loss drug approval in China....

Logo
634 Views
Share
bullishAlibaba
23 Jun 2025 08:08

ECM Weekly (23 June 2025) - Foshan Haitian, Sanhua, Anjoy, Sany, CaoCao, Eternal, Zhou Liu, HDB Fin

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
485 Views
Share
19 Jun 2025 09:30

Thematic Report: Ozempic- Weight Loss Drug Revolution

​Ozempic's remarkable efficacy in weight loss and chronic disease management has transformed it into a multi-billion-dollar drug, set to dominate...

Logo
476 Views
Share
11 Jun 2025 13:04

#161 India Insights: India Eyes Rare Earth Push; IndusInd's Prerequisites from RBI, Insulin Scale Up

​India aims to localize rare earth magnet production for EV and tech sectors, Hinduja Group faces RBI conditions for Indusind Bank

Logo
524 Views
Share
x